The global cardiovascular needle market was valued at around US$ 85.2 Mn at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 188.4 Mn by 2032.
Rising number of patients having cardiovascular diseases and increasing obesity and diabetes rate with geriatric population are the elements expected to set the tone of Cardiovascular Needle Market.
Cardiovascular diseases (CVDs), including conditions like cerebrovascular disease, coronary heart disease, rheumatic heart disease, and others, are abnormalities of the heart and blood arteries. A few of the main lifestyle factors that contribute to CVDs include smoking, unhealthy diet, and physical inactivity, all of which raise the risk of heart attacks and strokes. Diabetes, high cholesterol, and hypertension are additional risk factors for these illnesses.
Open heart surgery, cardiac valve procedures, heart transplant procedures, coronary artery bypass graft treatments, and other procedures all require cardiovascular needles. These needles come in different types such as single-use needles or eyeless needles and multiple-use needles or eyed needles. The new stainless steel alloys with high concentrations of nickel, Surgalloy, and Ethalloy are used to make these needles.
| Attributes | Details |
|---|---|
| Cardiovascular Needle Market Value in 2021 | US$ 85.2 Million |
| Cardiovascular Needle Market Value in 2032 | US$ 188.4 Million |
| Cardiovascular Needle Market CAGR (2022 to 2032) | 7.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Cardiovascular diseases are the leading cause of death globally, according to the World Health Organization (WHO). The biggest factor contributing to morbidity and mortality worldwide is still likely to be cardiovascular diseases (CVDs). According to WHO data, it is estimated that 17.9 million people worldwide pass away from cardiovascular diseases (CVDs) each year.
The global market for the cardiovascular needle is expected to expand as a result of the rising aging of the population and high smoking rates. Similarly, to this, it is expected that the market would have plenty of potentials to expand throughout the forecast period due to quick lifestyle changes, rising comorbidity, high tobacco use, and high obesity incidence.
The cardiovascular needle market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
A significant portion of the global market for cardiovascular needles is dominated by the North American region because of its developed healthcare systems and the introduction of advanced products like cardiovascular needles with laser drilling is anticipated to boost demand.
Due to the presence of major players, Europe retains the second spot in the global market. Although companies in this region also export to developing nations, which dominate the market in Europe.
East Asia is predicted to show lucrative growth owing to the high prevalence of cardiovascular diseases and affordable cardiovascular surgeries with the presence of skilled professionals.
Principal Consultant
Medline Industries Inc., KLS Martin Group, Sklar Surgical Instruments, Delacroix-Chevalier, Teleflex Incorporated, Wexler Surgical, Becton, Dickinson and Company, Surgins, Surtex Instruments Ltd., STILLE, Cardivon Surgical Inc., Symmetry Surgical Inc., B. Braun Melsungen AG, Rumex International Corporation, Scanlan International.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 7.5% 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Million, Volume in Units, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segment Covered | Type, Application, Usage, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel |
| Key Players | Medline Industries Inc.; KLS Martin Group; Sklar Surgical Instruments; Delacroix-Chevalier; Teleflex Incorporated; Wexler Surgical; Becton; Dickinson and Company; Surgins; Surtex Instruments Ltd.; STILLE; Cardivon Surgical Inc.; Symmetry Surgical Inc.; B. Braun Melsungen AG; Rumex International Corporation; Scanlan International |
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is likely to register a CAGR of 7.3% through 2032.
The market is currently valued at US$ 89.77 Mn in 2022.
The market is likely to grow to a valuation of US$ 181.6 Mn by 2032.
North America is likely to be a leading market during the forecast period.
Explore Healthcare Insights
View Reports
Cardiovascular Needle Market
